{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:51:19Z","timestamp":1773172279323,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:00:00Z","timestamp":1362787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00392-013-0552-7","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T04:21:56Z","timestamp":1362716516000},"page":"447-458","source":"Crossref","is-referenced-by-count":25,"title":["Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany"],"prefix":"10.1007","volume":"102","author":[{"given":"Ulrike","family":"Theidel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Asseburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Giannitsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,9]]},"reference":[{"issue":"3","key":"552_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12181-010-0273-3","volume":"4","author":"U Zeymer","year":"2010","unstructured":"Zeymer U, Zahn R, Gitt A et al (2010) Aktuelle Versorgungsstruktur der Therapie des akuten Herzinfarkts in Deutschland. Der Kardiologe 4(3):231\u2013235. doi: 10.1007\/s12181-010-0273-3","journal-title":"Der Kardiologe"},{"key":"552_CR2","unstructured":"Robert Koch-Insitut (2006) Koronare Herzkrankheit und akuter Myokardinfarkt, Heft 33. http:\/\/www.gbe-bund.de . Accessed 5 Dec 2010"},{"key":"552_CR3","unstructured":"AOK Bundesverband, FEISA, WidO (2007) Qualit\u00e4tssicherung der station\u00e4ren Versorgung mit Routinedaten (QSR) Abschlussbericht 2007. Wissenschaftliches Insitut der AOK, editor. http:\/\/www.wido.de . Accessed: 4 July 2011"},{"issue":"2","key":"552_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12181-011-0328-0","volume":"5","author":"K Damm","year":"2011","unstructured":"Damm K, Runge C, Zeymer U et al (2011) Krankheitskosten des akuten Koronarsyndroms in Deutschland. Der Kardiologe 5(2):122\u2013128. doi: 10.1007\/s12181-011-0328-0","journal-title":"Der Kardiologe"},{"issue":"7","key":"552_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00392-012-0421-9","volume":"101","author":"C Zobel","year":"2012","unstructured":"Zobel C, Dorpinghaus M, Reuter H et al (2012) Mortality in a cardiac intensive care unit. Clin Res Cardiol 101(7):521\u2013524. doi: 10.1007\/s00392-012-0421-9","journal-title":"Clin Res Cardiol"},{"issue":"16","key":"552_CR6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jama.295.16.1912","volume":"295","author":"ED Peterson","year":"2006","unstructured":"Peterson ED, Roe MT, Mulgund J et al (2006) Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295(16):1912\u20131920. doi: 10.1001\/jama.295.16.1912","journal-title":"JAMA"},{"issue":"20","key":"552_CR7","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31(20):2501\u20132555. doi: 10.1093\/eurheartj\/ehq277","journal-title":"Eur Heart J"},{"issue":"11","key":"552_CR8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045\u20131057","journal-title":"N Engl J Med"},{"issue":"5","key":"552_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","volume":"124","author":"KW Mahaffey","year":"2011","unstructured":"Mahaffey KW, Wojdyla DM, Carroll K et al (2011) Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 124(5):544\u2013554. doi: 10.1161\/CIRCULATIONAHA.111.047498","journal-title":"Circulation"},{"key":"552_CR10","unstructured":"AstraZeneca (2011) Fachinformation Brilique, Stand: Oktober 2011. Rote Liste\u00ae Service GmbH, editor. http:\/\/www.fachinfo.de . Accessed 28 June 2012"},{"key":"552_CR11","unstructured":"Gemeinsamer Bundesausschuss (2011) Ticagrelor\u2014Dossier zur Nutzenbewertung gem\u00e4\u00df \u00a735a SGB V: Modul 4 Kodierung. http:\/\/www.g-ba.de . Accessed 11 Apr 2011"},{"key":"552_CR12","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2011) Ticagrelor\u2014Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V: Dossierbewertung; Auftrag: A11-02. http:\/\/www.iqwig.de . Accessed 24 Oct 2011"},{"key":"552_CR13","doi-asserted-by":"crossref","unstructured":"Henriksson M, Nikolic E, Janzon M, Hauch O, Levin LA, Wallentin L, For the PLATO health economic substudy group (2011) Long-term costs and health outcomes of treating acute coronary syndrome patients with ticagrelor based on the EU label\u2014Cost-effectiveness analysis based on the PLATO study. Value in Health","DOI":"10.1016\/j.jval.2011.02.233"},{"key":"552_CR14","author":"E Nikolic","year":"2012","unstructured":"Nikolic E, Janzon M, Hauch O et al (2012) Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12\u00a0months: results from the PLATO study. Eur Heart J. doi: 10.1093\/eurheartj\/ehs149","journal-title":"Eur Heart J"},{"key":"552_CR15","author":"KG Haeusler","year":"2011","unstructured":"Haeusler KG, Konieczny M, Endres M et al (2011) Impact of anticoagulation before stroke on stroke severity and long-term survival. Int J Stroke. doi: 10.1111\/j.1747-4949.2011.00672.x","journal-title":"Int J Stroke"},{"key":"552_CR16","unstructured":"Gesundheitsberichterstattung des Bundes (2012) Diagnosedaten der Krankenh\u00e4user ab 2000 (F\u00e4lle\/Sterbef\u00e4lle, Berechnungs- und Belegungstage, durchschnittliche Verweildauer). Gliederungsmerkmale: Jahre, Behandlungsort, Alter, Geschlecht, Verweildauer, ICD10. http:\/\/www.gbe-bund.de . Accessed 23 Oct 2011"},{"issue":"3","key":"552_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1185\/030079906X167462","volume":"23","author":"MJ Taylor","year":"2007","unstructured":"Taylor MJ, Scuffham PA, McCollam PL et al (2007) Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr Med Res Opin 23(3):495\u2013503","journal-title":"Curr Med Res Opin"},{"key":"552_CR18","unstructured":"Gesundheitsberichterstattung des Bundes (2011) Krankheitskosten je Einwohner in \u20ac. Gliederungsmerkmale: Jahre, Deutschland, Alter, Geschlecht, ICD10, Einrichtungen. http:\/\/www.gbe-bund.de . Accessed 23 Oct 2011"},{"key":"552_CR19","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2009) Arbeitspapier Kostenbestimmung V1.0. http:\/\/www.iqwig.de . Accessed 11 Apr 2011"},{"key":"552_CR20","unstructured":"Janzon M, Lundborg E, Henriksson M et al. (2010) Abstract 17295: Health Economics in the PLATelet inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns. Circulation 122 (21_MeetingAbstracts): A17295"},{"key":"552_CR21","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2009) Arbeitspapier Modellierung V1.0. http:\/\/www.iqwig.de . Accessed 11 Apr 2011"},{"key":"552_CR22","unstructured":"N\u00f6then M (2011) Hohe Kosten im Gesundheitswesen: Eine Frage des Alters? Statistisches Bundesamt, editor. http:\/\/www.destatis.de . Accessed 11 Apr 2011"},{"key":"552_CR23","unstructured":"Anonym (2012) Preismeldungen. LAUER-FISCHER GmbH, editor. https:\/\/www.lauer-fischer.de\/LF\/Seiten\/Verwaltung\/Kundencenter.aspx . Accessed 29 June 2012"},{"key":"552_CR24","unstructured":"Institut f\u00fcr das Entgeltsystem im Krankenhaus (2011) DRG Browser. http:\/\/www.g-drg.de . Accessed 05 Dec 2011"},{"key":"552_CR25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10389-005-0112-3","volume":"13","author":"B Br\u00fcggenj\u00fcrgen","year":"2005","unstructured":"Br\u00fcggenj\u00fcrgen B, Rupprecht HJ, Willich SN (2005) Cost of atherothrombotic diseases-myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease-in Germany. J Public Health 13:216\u2013224","journal-title":"J Public Health"},{"key":"552_CR26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1468-1331.2005.01091.x","volume":"12","author":"K Rossnagel","year":"2005","unstructured":"Rossnagel K, Nolte CH, M\u00fcller-Nordhorn J et al (2005) Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol 12:862\u2013868","journal-title":"Eur J Neurol"},{"issue":"440","key":"552_CR27","first-page":"447","volume":"33","author":"J Zeidler","year":"2008","unstructured":"Zeidler J, Mittendorf T, Vahldiek G et al (2008) Kostenvergleichsanalyse der ambulanten und station\u00e4ren kardiologischen Rehabilitation. Herz 33(440):447","journal-title":"Herz"},{"issue":"2","key":"552_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00019053-200624020-00005","volume":"24","author":"M Lamotte","year":"2006","unstructured":"Lamotte M, Annemanns L, Evers T et al (2006) A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Pharmacoeconomics 24(2):155\u2013169","journal-title":"Pharmacoeconomics"},{"key":"552_CR29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00115-008-2505-3","volume":"79","author":"Y Winter","year":"2008","unstructured":"Winter Y, Wolfram C, Sch\u00f6ffski O et al (2008) Langzeitkrankheitskosten 4 Jahre nach Schlaganfall oder TIA in Deutschland. Nervenarzt 79:918\u2013926","journal-title":"Nervenarzt"},{"issue":"1","key":"552_CR30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1185\/030079908X253762","volume":"24","author":"K Berger","year":"2008","unstructured":"Berger K, Hessel F, Kreuzer J et al (2008) Clopidogrel versus aspirin in patients with atherothrombosis: cAPRIE-based calculation of cost-effectiveness for Germany. Curr Med Res Opin 24(1):267\u2013274","journal-title":"Curr Med Res Opin"},{"key":"552_CR31","unstructured":"Gesundheitsberichterstattung des Bundes (2011) Arbeitsunf\u00e4higkeit bei AOK-Pflichtmitgliedern ohne Rentner (Arbeitsunf\u00e4higkeitsf\u00e4lle, Arbeitsunf\u00e4higkeitsf\u00e4lle je 100.000 Pflichtmitglieder, Arbeitsunf\u00e4higkeitstage, Arbeitsunf\u00e4higkeitstage je 100.000 Pflichtmitglieder,Tage je Fall). Gliederungsmerkmale: Jahre, Deutschland, Geschlecht, ICD-10. http:\/\/www.gbe-bund.de . Accessed 23 Oct 2011"},{"key":"552_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2007-963505","volume":"12","author":"JM Schulenburg","year":"2007","unstructured":"Schulenburg JM, Greiner W, Jost F et al (2007) Deutsche Empfehlungen zur gesundheits\u00f6konomischen Evaluation\u2014dritte und aktualisierte Fassung des Hannoveraner Konsens. Gesundh \u00f6kon Qual manag 12:285\u2013290","journal-title":"Gesundh \u00f6kon Qual manag"},{"key":"552_CR33","doi-asserted-by":"crossref","unstructured":"Theidel U, Asseburg C, Giannitsis E, Katus H. Cost effectiveness of ticagrelor in the treatment of acute coronary syndrome (ACS) in Germany Abstract submitted to ISPOR 14th Annual European Congress. 2011","DOI":"10.1016\/j.jval.2011.08.790"},{"key":"552_CR34","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-49559-8","volume-title":"Gesundheits\u00f6konomische Evaluationen","author":"O Sch\u00f6ffski","year":"2007","unstructured":"Sch\u00f6ffski O, Schulenburg JM (2007) Gesundheits\u00f6konomische Evaluationen, 3rd edn. Springer, Berlin","edition":"3"},{"issue":"3","key":"552_CR35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1185\/030079905X30725","volume":"21","author":"M Cohen","year":"2005","unstructured":"Cohen M (2005) Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes. Curr Med Res Opin 21(3):439\u2013445. doi: 10.1185\/030079905X30725","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"552_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00392-010-0160-8","volume":"99","author":"S Stracke","year":"2010","unstructured":"Stracke S, Dorr O, Heidt MC et al (2010) GRACE risk score as predictor of in-hospital mortality in patients with chest pain. Clin Res Cardiol 99(10):627\u2013631. doi: 10.1007\/s00392-010-0160-8","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"552_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0828-282X(07)70229-5","volume":"23","author":"D Fitchett","year":"2007","unstructured":"Fitchett D (2007) The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk. Can J Cardiol 23(8):663\u2013671","journal-title":"Can J Cardiol"},{"key":"552_CR38","doi-asserted-by":"crossref","unstructured":"Bufe A, Frey S, Briswalter S (2009) Durch Blutungen verursachte Kosten bei der Therapie des akuten Koronarsyndroms in Deutschland. Herz 479; 484","DOI":"10.1007\/s00059-009-3189-6"},{"issue":"5","key":"552_CR39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.STR.0000217450.21310.90","volume":"37","author":"PL Kolominsky-Rabas","year":"2006","unstructured":"Kolominsky-Rabas PL, Heuschmann PU, Marschall D et al (2006) Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 37(5):1179\u20131183","journal-title":"Stroke"},{"issue":"4","key":"552_CR40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/eurheartj\/ehn509","volume":"30","author":"B Schweikert","year":"2009","unstructured":"Schweikert B, Hunger M, Meisinger C et al (2009) Quality of life several years after myocardial infarction: comparing the MONICA\/KORA registry to the general population. Eur Heart J 30(4):436\u2013443. doi: 10.1093\/eurheartj\/ehn509","journal-title":"Eur Heart J"},{"key":"552_CR41","unstructured":"AstraZeneca. PLATO\u2014A Study of PLATelet inhibition and Patient Outcomes (clinical study report). [unver\u00f6ffentlicht] 2009"},{"key":"552_CR42","doi-asserted-by":"crossref","unstructured":"Dyer MTD, Goldsmith KA, Sharples LS et al. (2010) Are view of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Out 8: 13","DOI":"10.1186\/1477-7525-8-13"},{"key":"552_CR43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00103-002-0405-4","volume":"45","author":"G Wiesner","year":"2002","unstructured":"Wiesner G, Grimm J, Bittner E (2002) Vorausberechnungen des Herzinfarktgeschehens in Deutschland. Bundesgesundheitsblatt 45:438\u2013445","journal-title":"Bundesgesundheitsblatt"},{"key":"552_CR44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00392-004-0109-x","volume":"93","author":"CW Hamm","year":"2004","unstructured":"Hamm CW (2004) Leitlinien: Akutes Koronarsyndrom (ACS), Teil 2. Z Kardiol 93:324\u2013341","journal-title":"Z Kardiol"},{"key":"552_CR45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00392-004-1064-2","volume":"93","author":"CW Hamm","year":"2004","unstructured":"Hamm CW (2004) Leitlinien: Akutes Koronarsyndrom (ACS), Teil 1. Z Kardiol 93:72\u201390","journal-title":"Z Kardiol"},{"key":"552_CR46","unstructured":"Anonym (2010) Threshold values for intervention cost-effectiveness by Region. Accessed 23 Oct 2010"},{"issue":"1","key":"552_CR47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1524-4733.2005.03070.x","volume":"8","author":"M Barbieri","year":"2005","unstructured":"Barbieri M, Drummond M, Willke R et al (2005) Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. Value Health 8(1):10\u201323","journal-title":"Value Health"},{"key":"552_CR48","unstructured":"AstraZeneca. EMEA\/H\/C\/1241: Ticagrelor Tablets Additional PLATO subgroup analysis on overall PLATO UA\/NSTEMI and STEMI subgroups and ASA \u0393\u00eb\u00f1150\u00a0mg cohort for the German Value Dossier. 2011"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-013-0552-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-013-0552-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-013-0552-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T16:47:23Z","timestamp":1562777243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-013-0552-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,9]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s00392-013-0552-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,9]]}}}